Status:
COMPLETED
Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis
Lead Sponsor:
San Filippo Neri General Hospital
Conditions:
Hereditary Hemochromatosis
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of study is to determine the best and durable choice of treatment between phlebotomy and eritrocytoapheresis in the medium- and long-term clinical management of HH
Detailed Description
Patients affected by Hereditary hemochromatosis need a completeinitial staging of disease, a correct clinical management, a good chance of treatment and long-term follow-up. Clinical manifestations at...
Eligibility Criteria
Inclusion
- Patiens newly diagnosed having Hereditary Hemochromatosis
Exclusion
- Age \< 18 yrs.
- Not obese (BMI \<30)
- Not consuming alchol beverages,
- Not affected by systemic diseases and known hepatic viruses
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
End Date :
December 1 2006
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00440986
Start Date
April 1 2003
End Date
December 1 2006
Last Update
March 1 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Transfusion Medicine-San Filippo Neri General Hospital
Rome, Italy, 00135